Showing results (291-300 of 342) with videos related to

Sort By:
Pageof 35
Respiratory Investigation|July 5, 2025
Incidence and clinical significance of acute exacerbation of interstitial lung disease in patients with primary Sjögren's syndromeTomoyuki Fujisawa, Yuko Tanaka, Yosuke Kamiya, et al.
Respiratory Investigation|September 4, 2019
Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidoneMasato Kono, Yutaro Nakamura, Noriyuki Enomoto, et al.
Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.
Thorax|November 11, 2022
Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort studyYuya Aono, Hironao Hozumi, Masato Kono, et al.
Chest|November 7, 2024
Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based AnalysisHironao Hozumi, Yoshinari Endo, Masato Kono, et al.
JAMA Network Open|May 2, 2023
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical TrialMasakazu Abe, Takuhiro Yamaguchi, Yukiyoshi Fujita, et al.
Respiratory Medicine|April 2, 2018
Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumoniaKatsuhiro Yoshimura, Masato Kono, Yasunori Enomoto, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Respiratory Medicine|February 1, 2017
Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE)Yoshiyuki Oyama, Noriyuki Enomoto, Yuzo Suzuki, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
Pageof 35